Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size Expected to Be by 2034?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market has seen solid growth, rising from $1.29 billion in 2024 to $1.38 billion in 2025 at a CAGR of 7.2%, influenced by aging populations, better diagnosis, improved healthcare access, and tailored therapies.

The benign prostatic hyperplasia (BPH) treatment devices and equipment market is expected to grow significantly in the next few years. It will reach $1.8 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. The growth is driven by the adoption of minimally invasive techniques, expansion in emerging markets, regulatory support, and the move toward value-based healthcare. Key trends include non-surgical procedures, laser and radiofrequency technologies, telemedicine, and patient engagement.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

What Are the Emerging Segments Within the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented -

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

What Long-Term Drivers Are Shaping Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends?
The rising incidence of prostate cancer is likely to accelerate growth in the benign prostatic hyperplasia market. Prostate cancer, which develops in the prostate gland, leads many aging men to seek medical care, during which benign prostatic hyperplasia is often identified and managed. For instance, the American Society of Clinical Oncology reported in February 2023 that 288,300 men in the U.S. were living with prostate cancer, with 268,490 new cases and 34,500 deaths reported in 2022. This trend is expected to boost demand in the benign prostatic hyperplasia market.

Who Are the Top Competitors in Key Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Segments?
Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

What Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends Are Gaining Traction Across Different Segments?
Companies in the benign prostatic hyperplasia (BPH) market are developing innovative solutions such as the UroLift 2 System and UroLift ATC advanced tissue control system for treating lower urinary tract symptoms. For example, in May 2022, Teleflex Incorporated introduced the UroLift 2 System and UroLift ATC, which provide minimally invasive treatments for an enlarged prostate by lifting tissue to clear the urethra and improve urinary flow.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Which Regions Are Becoming Hubs for Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Innovation?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
2. What is the CAGR expected in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
3. What Are the Key Innovations Transforming the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Industry?
4. Which Region Is Leading the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.